Indeed, we found that p38α pharmacological inhibition induces the downregulation of several β-catenin target genes, including c-MYC, showing that p38α is involved in several key functions of CRC cells, including proliferation, migration, and chemoresistance [22]. The gene discussed is MYC; the disease is colorectal carcinoma.